The Covid-19 pandemic reduced life expectancy in 2020 by the largest amount since World War Two, according to a study published on Sept. 27 by Oxford University, with the life expectancy of American men dropping by more than two years.
A federal judge on Sept. 24 ruled that a Cincinnati, Ohio-area healthcare provider could require employees to get vaccinated against Covid-19 or risk losing their job, in what appears to be the first ruling of its kind for a private employer in the United States.
The U.S. Centers for Disease Control and Prevention (CDC) on Sept. 24 backed a booster shot of the Pfizer and BioNTech Covid-19 vaccine for Americans aged 65 and older, adults with underlying medical conditions and adults in high-risk working and institutional settings.
Sinovac’s Covid-19 vaccine is highly effective against serious illness, although rival shots from Pfizer/BioNTech and AstraZeneca showed better protection rates, a large real world study from Malaysia showed.
Why aren’t more people getting vaccinated? The answer comes down to a lack of trust, according to the COVID States Project, the largest ongoing national survey tracking people’s opinions and behaviors during the pandemic.
The United States plans to donate an additional 500 million Covid-19 vaccines made by Pfizer Inc. and BioNTech SE to nations around the world, lifting the total the country is sharing to more than 1 billion doses, according to a source familiar with the plans.
September 20, 2021, marked a grisly milestone for the United States, recording more American deaths from Covid-19 than from the 1918–1919 Spanish flu.
Paris-based Jeito Capital announced the final close on its first fund, which is the largest venture capital fund in Europe focused on life sciences.
Vifor Pharma and Travere Therapeutics inked a collaboration and licensing partnership to commercialize sparsentan in Europe, Australia and New Zealand. The drug is being developed to treat FSGS and IgAN, which are rare progressive kidney diseases that are leading causes of end-stage kidney disease.
A third shot of Sinopharm’s Covid-19 vaccine leads to a rebound in antibody levels that drop months after a second dose, a small-scale Chinese study showed.